Occupe actuellement des postes chez CRISPR Therapeutics AG, Genocea Biosciences Inc and Adaptimmune Therapeutics PLC
Position | Company | Period |
---|---|---|
Independent Director | CRISPR Therapeutics AG | 1 avril 2015 - |
Independent Director | Genocea Biosciences Inc | 8 février 2018 - |
Non-Executive Independent Director | Adaptimmune Therapeutics PLC | 1 septembre 2014 - |
Independent Director | Nevro Corp | 1 septembre 2014 - 19 mars 2019 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-07-19 | 2023-07-17 |
Savara Inc
(SVRA)
|
A Achat |
333 333
+1.4%
3,00999 999 USD |
333 333 +1.4% | 3,00 | 999 999 USD | |
2022-05-26 | 2022-05-25 |
Genocea Biosciences Inc
(GNCA)
|
V Vente |
4 445 093
-100.0%
0,08362 720 USD |
4 445 093 -100.0% | 0,08 | 362 720 USD | |
2022-05-26 | 2022-05-24 |
Genocea Biosciences Inc
(GNCA)
|
V Vente |
5 931 843
-57.2%
0,07387 943 USD |
5 931 843 -57.2% | 0,07 | 387 943 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
948 948
+inf%
1,901 803 001 USD |
948 948 +inf% | 1,90 | 1 803 001 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
2 631 578
+33.8%
1,904 999 998 USD |
2 631 578 +33.8% | 1,90 | 4 999 998 USD | |
2021-10-19 | 2021-10-18 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
1 851 852
0,000 USD |
1 851 852 | 0,00 | 0 USD | |
2021-03-18 | 2021-03-16 |
Marker Therapeutics Inc
(MRKR)
|
A Achat |
5 714 285
+114.3%
1,759 999 999 USD |
5 714 285 +114.3% | 1,75 | 9 999 999 USD | |
2020-12-07 | 2020-12-04 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
4 398 602
+214.3%
0,622 735 930 USD |
4 398 602 +214.3% | 0,62 | 2 735 930 USD | |
2020-09-22 | 2020-09-18 |
Metacrine, Inc.
(MTCR)
|
A Achat |
769 230
+33.6%
13,009 999 990 USD |
769 230 +33.6% | 13,00 | 9 999 990 USD | |
2020-07-28 | 2020-07-24 |
Genocea Biosciences Inc
(GNCA)
|
A Achat |
3 151 260
+43.6%
2,257 090 335 USD |
3 151 260 +43.6% | 2,25 | 7 090 335 USD | |
2020-07-01 | 2020-06-30 |
Akouos Inc
(AKUS)
|
A Achat |
588 235
+15.9%
17,009 999 995 USD |
588 235 +15.9% | 17,00 | 9 999 995 USD | |
2020-04-13 | 2020-04-03 |
Trevi Therapeutics Inc
(TRVI)
|
V Vente |
564
-0.0%
2,661 500 USD |
564 -0.0% | 2,66 | 1 500 USD | |
2020-02-05 | 2020-02-03 | A Achat |
800 000
+30.2%
19,0015 200 000 USD |
800 000 +30.2% | 19,00 | 15 200 000 USD | ||
2020-01-28 | 2020-01-24 |
Adaptimmune Therapeutics PLC
(ADAP)
|
A Achat |
7 500 000
+62.5%
0,675 000 250 USD |
7 500 000 +62.5% | 0,67 | 5 000 250 USD | |
2019-07-24 | 2019-07-22 |
Mirum Pharmaceuticals Inc
(MIRM)
|
A Achat |
450 000
+12.0%
15,006 750 000 USD |
450 000 +12.0% | 15,00 | 6 750 000 USD | |
2019-06-25 | 2019-06-24 |
Genocea Biosciences Inc
(GNCA)
|
A Achat |
2 857 142
+65.4%
3,509 999 997 USD |
2 857 142 +65.4% | 3,50 | 9 999 997 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
1 500 000
+51.0%
10,0015 000 000 USD |
1 500 000 +51.0% | 10,00 | 15 000 000 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
1 000 000
+51.6%
10,0010 000 000 USD |
1 000 000 +51.6% | 10,00 | 10 000 000 USD | |
2019-05-09 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
1 136 704
+124.1%
1,081 227 640 USD |
1 136 704 +124.1% | 1,08 | 1 227 640 USD | |
2019-02-19 | 2019-02-14 |
Genocea Biosciences Inc
(GNCA)
|
A Achat |
9 948 269
+39.8%
0,474 688 619 USD |
9 948 269 +39.8% | 0,47 | 4 688 619 USD |